fotokostic/iStock via Getty Images Update 9:25pm: Adds details on remedy offered. Bunge Global (NYSE:BG) offered remedies to the European Union regulators for its planned $8.2 billion purchase of Viterra Inc. as it tries to win antitrust approval for the deal. Bunge (BG) offered the commitments to the European Commission onContinue Reading
JHVEPhoto Venture capital firm Andreessen Horowitz has purchased and stashed thousands of GPUs, including many of Nvidia’s (NASDAQ:NVDA) H100 processors, in an effort to win deals for AI startups, The Information reported. The venture capital firm, which has $42B in assets under management, has rented out the GPUs to manyContinue Reading
Christopher Furlong/Getty Images News British home building stocks climbed Friday following the Labour Party’s landslide win in the U.K. general election, and that stock sector is among four others likely to benefit from the center-left party’s victory, Interactive Investor said. The Labour Party on Thursday picked up 211 seats, leavingContinue Reading
IvelinRadkov Sanofi (NASDAQ:SNY) and its partner Regeneron (NASDAQ:REGN) announced Wednesday that the EU drug regulator, the European Medicines Agency (EMA), has approved a label expansion for their asthma therapy Dupixent to include patients with the lung disorder, chronic obstructive pulmonary disease (COPD). The approval marks the first time a globalContinue Reading
Andrii Dodonov Update 2.00PM EST: Adds latest share move and Oppenheimer’s downgrade Cell therapy developer Cartesian Therapeutics (NASDAQ:RNAC) announced Tuesday that its lead asset, Descartes-08, reached the main goal in a mid-stage trial against the muscle disorder myasthenia gravis (MG). In conjunction with the data, the Gaithersburg, Maryland-based biotech announcedContinue Reading
krblokhin Fannie Mae (OTCQB:FNMA) surged more than 9% on Friday amid higher odds of a Donald Trump election win after the Presidential debate Thursday night. Investors believe that Trump is more likely to end FNMA’s conservatorship than the Biden administration. Some deal name stocks such as Matterport (MTTR), which agreedContinue Reading
Eric Broder Van Dyke Live Nation (NYSE:LYV) rose 4% amid a report that the U.S. Justice Department’s antitrust lawsuit against the concert promoter won’t go to trial until 20026. The shares may also be helped by higher odds of a Donald Trump win after the Presidential debate Thursday night. U.S.Continue Reading
Genmab (GMAB) and partner AbbVie (NYSE:ABBV) have received U.S. FDA approval for their monoclonal antibody Epkinly (epcoritamab-bysp) for the treatment of adults with relapsed or refractory follicular lymphoma. The approval is based on results from Phase 1/2 EPCORE NHL-1 study, which demonstrated durable, clinically meaningful treatment responses in patients withContinue Reading
JHVEPhoto/iStock Editorial via Getty Images Private equity firm Carlyle (CG) and KKR (KKR) won an auction for Discover Financial’s (NYSE:DFS) $10 billion student loan book. The joint bid from the PE firms beat out a competing offer from Sixth Street, BlackRock (BLK) and the Canada Pension Plan Investment Board, withContinue Reading
U.Today – U.Today has prepared a summary of the top three news stories over the weekend. Schiff predicts price will keep falling for several years On Friday, June 21, Peter Schiff heaped yet another portion of criticism on Bitcoin, the flagship cryptocurrency. In his X post, Schiff noted that sinceContinue Reading
